ClinicalTrials.Veeva

Menu

COVID-19 and Lingering Symptoms in Primary Care Patients (CALIP)

K

Katarina Hedin

Status

Completed

Conditions

Symptoms and Signs
Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04813731
2020-05448

Details and patient eligibility

About

The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-CoV-2 infection vary and most people with COVID-19 experience illness of mild or moderate severity and recover with symptomatic treatment outside of hospital. Studies have found that some people experience lingering/long-lasting symptoms and only a minority of patients were completely free from COVID-19 related symptoms after two months. About one third still had up to two residual symptoms and 55% had three or more. As far as we know no study on lingering symptoms has been published in patients after a mild or moderate infection managed in primary care settings. The aim of this study is to explore the course of disease over a one year period and describe lingering symptoms and their impact on well-being and daily activities in adult non-hospitalized patients with previous established COVID-19 infection.

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Confirmed SARS-CoV-2 infection, either by polymeras chain reaction (PCR), or by antigen testing (if authorized/recommended/used by national/local governments)
  • Symptoms consistent with mild to moderate COVID-19
  • Maximum of 2 weeks since positive SARS-CoV-2 test
  • Aged 18 years and older
  • Patient able and willing to comply with monthly phone calls.

Exclusion criteria

  • Hospitalisation due to COVID-19

Trial contacts and locations

13

Loading...

Central trial contact

Katarina Hedin, Ass prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems